AVT vs ITRI

AVT's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial health. The Graham Number suggests a defensive fair value of $59.95, implying the current price of $50.83 is slightly undervalued, though growth-based intrinsic value is much lower at $18.76. Profitability metrics are weak, with low margins and declining earnings, but the balance sheet shows strength via a solid current ratio and moderate leverage. Despite mixed signals, the stock appears fairly valued with moderate risks and limited near-term catalysts.

ITRI exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a highly attractive valuation profile, trading significantly below its growth-based intrinsic value of $191.75. While the technical trend is bearish and insider sentiment is low, the company's profitability is robust with an ROE of 19.26% and a PEG ratio of 0.82, indicating the stock is undervalued relative to its earnings growth. The primary concern is a recent decline in revenue growth (-6.70%), though this is heavily offset by massive earnings growth (73.60%) and a consistent track record of earnings beats. Overall, the data suggests a value-driven entry point for a company with strong operational efficiency.